While some countries are already seeing progress in containing or the slowing down of the spread of the coronavirus, millions of people are still affected by COVID-19 elsewhere. As scientists ramp up efforts in developing a cure for COVID-19, a group of researchers has proposed a kind of vaccine that could be transmitted.
Express reports researchers have proposed developing a kind of vaccine that could be transmitted from person to person. Called “self-disseminating vaccines,” they explain that this kind of COVID-19 cure could potentially prevent transmission of coronaviruses between animals and humans. However, this unusual method also comes with risks, such as the possibility of an accidental mutation that could have a negative or fatal effect on humans and wildlife. This risk comes despite the method being economical.
This proposal was in a piece published in Nature magazine called “Self-disseminating vaccines to suppress zoonoses.” The authors of the piece noted how advances in genetic engineering can help solve health crises like this through vaccines that could be transmitted from one person to another.
According to the University of Idaho’s James J. Bull and Scott L. Nuismer, “It is now more apparent than ever that we need a better and more proactive approach,” in stopping coronavirus outbreaks. The two researchers also explain a kind of method of vaccines that could self-transmit through “wild animal reservoirs” to keep the disease from potentially infecting human populations. The downside to this method is that it could bring the original virus back to its harmful state among other “unintended” effects.
Previously, another group of researchers has made a breakthrough in finding a potential COVID-19 cure. Researchers from the University of Bristol led by Professor Christiane Schaffitzel of the School of Biology and Professor Imre Berger from the Max Planck Bristol Center for Minimal Biology found that the coronavirus has a “pocket” on its surface that could be injected with antiviral drugs. This would stop the virus before it even enters a human cell. They found that the virus makes use of a molecule called linoleic acid to bind itself to human cells, and from there it starts replicating.
With these findings, the researchers are now faced with a challenge of how to use this attribute of the virus against itself to end the pandemic.


Trump Administration Releases New UFO Files and Apollo Mission Records
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
FDA Weighs Safety Standards for Psychedelic Therapies
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Neuralink Expands Brain Implant Trials with 12 Global Patients
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 



